950
Views
100
CrossRef citations to date
0
Altmetric
Review

Polyhydroxyalkanoate (PHA): applications in drug delivery and tissue engineering

, , , , &
Pages 467-482 | Received 02 Apr 2019, Accepted 02 May 2019, Published online: 16 May 2019

References

  • Tan G-YA, Chen C-L, Li L, et al. Start a research on biopolymer polyhydroxyalkanoate (PHA): a review. Polymers (Basel). 2014;6:706–754.
  • Jacquel N, Lo C, Wu H, et al. Solubility of polyhydroxyalkanoates by experiment and thermodynamic correlations. AIChE J. 2007;53:2704–2714.
  • Noda I, Lindsey SB, Carraway D. Plastics from Bacteria: natural functions and applications G.-Q. Chen, Vol. 14, Berlin: Springer. 2010;237–255.
  • Chee J-Y, Yoga -S-S, Lau N-S, et al. Bacterially produced polyhydroxyalkanoate (PHA): converting renewable resources into bioplastics. Curr Res Technol Educ Top Appl Microbiol Microb Biotechnol. 2010;2:1395–1404.
  • Chan CH, Chia CH, Thomas S. Physical Chemistry of Macromolecules: macro to Nanoscales. Toronto, New Jersey: CRC Press; 2014.
  • Castilho LR, Mitchell DA, Freire DMG. Production of polyhydroxyalkanoates (PHAs) from waste materials and by-products by submerged and solid-state fermentation. Bioresour Technol. 2009;100:5996–6009.
  • Rehm BHA. Biogenesis of microbial polyhydroxyalkanoate granules: a platform technology for the production of tailor-made bioparticles. Curr Issues Mol Biol. 2007;9:41.
  • Lenz RW, Marchessault RH. Bacterial polyesters: biosynthesis, biodegradable plastics and biotechnology. Biomacromolecules. 2005;6:1–8.
  • Rehm BHA. Genetics and biochemistry of polyhydroxyalkanoate granule self-assembly: the key role of polyester synthases. Biotechnol Lett. 2006;28:207–213.
  • L.G. Donaruma - Microbial polyesters, by Yoshiharu Doi, VCH, New York, 1990, 156.
  • Taguchi K, Aoyagi Y, Matsusaki H, et al. Co-expression of 3-ketoacyl-ACP reductase and polyhydroxyalkanoate synthase genes induces PHA production in Escherichia coli HB101 strain. FEMS Microbiol Lett. 1999;176:183–190.
  • Pouton CW, Akhtar S. Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Adv Drug Delivery Rev. 1996;18:133–162.
  • Mumtaz T, Abd-Aziz S, Yee PL, et al. Synthesis, characterization, and structural properties of intracellular copolyester poly(3-hydroxybutyrate-co-3-hydroxyvalerate) produced by comamonas sp. EB 172 from renewable resource. Int J Polym Anal Charact. 2010;15:329–340.
  • Rahman NA, Wasoh H, Yee PL, et al. Visualization of Core-Shell PHBV Granules of Wild Type Comamonas sp. EB172 In Vivo under Transmission Electron Microscope. Int J Polym Anal Charact. 2011;16:228–238.
  • Sudesh K, Maehara A, Gan Z, et al. Direct observation of polyhydroxyalkanoate granule-associated-proteins on native granules and on poly(3-hydroxybutyrate) single crystals by atomic force microscopy. Polym Degrad Stab. 2004;83:281–287.
  • Abe H, Tsuge T, Mizuno S, et al. Real-Time Observation of Enzymatic Polyhydroxyalkanoate Polymerization Using High-Speed Scanning Atomic Force Microscopy. ACS Omega. 2017;2:181–185.
  • Chen G-Q, Da Silva LF, Shishatskaya EI, et al. Polyhydroxyalkanoates (PHA) for therapeutic applications. Mater Sci Eng C. 2018;86:144–150.
  • Butt FI, Muhammad N, Hamid A, et al. Recent progress in the utilization of biosynthesized polyhydroxyalkanoates for biomedical applications – review. Int J Biol Macromol. 2018;120:1294–1305.
  • Thorat Gadgil BS, Killi N, Rathna GVN. Polyhydroxyalkanoates as biomaterials. Medchemcomm. 2017;8:1774–1787.
  • Verlinden RAJ, Hill DJ, Kenward MA, et al. Bacterial synthesis of biodegradable polyhydroxyalkanoates. J Appl Microbiol. 2007;102:1437–1449.
  • Sendil D, Gürsel I, Wise DL, et al. Antibiotic release from biodegradable PHBV microparticles. J Control Release. 1999;59:207–217.
  • Park SJ, Lee SY, Lee Y. Biosynthesis of (R)-3-hydroxyalkanoic acids by metabolically engineered Escherichia coli. Appl Biochem Biotechnol. 2004;114:373–379.
  • Lu J, Tappel RC, Nomura CT. Mini-review: biosynthesis of poly (hydroxyalkanoates). J Macromol Sci Part C Polym Rev. 2009;49:226–248.
  • Michalak M, Marek AA, Zawadiak J, et al. Synthesis of PHB-based carrier for drug delivery systems with pH-controlled release. Eur Polym J. 2013;49:4149–4156.
  • Gumel AM, Annuar MSM, Chisti Y. Recent advances in the production, recovery and applications of polyhydroxyalkanoates. J Polym Environ. 2013;21:580–605.
  • Visakh PM. Polyhydroxyalkanoates (PHAs), their Blends, Composites and Nanocomposites: state of the Art, New Challenges and Opportunities. Cambridge, Uk: Royal Society of Chemistry. 2014.
  • Bäckström BT, Brockelbank JA, Rehm BHA. Recombinant Escherichia coli produces tailor-made biopolyester granules for applications in fluorescence activated cell sorting: functional display of the mouse interleukin-2 and myelin oligodendrocyte glycoprotein. BMC Biotechnol. 2007;7:3.
  • Martins AO, Araújo WL, Fernie AR, et al. 2-Oxoglutarate: linkingTCA cycle function with amino acid, glucosinolate, flavonoid, alkaloid, and gibberellin biosynthesis. Front Plant Sci. 2014;5:552.
  • Rehm BHA, Steinbüchel A. Polyhydroxyalkanoate (PHA) synthases: the key enzymes of PHA synthesis. Biopolym. online. 2002. doi:10.1002/3527600035.bpol3a06
  • Ojumu TV, Yu J, Solomon BO. Production of polyhydroxyalkanoates, a bacterial biodegradable polymers. Afr J Biotechnol. 2004;3:18–24.
  • Qin L-F, Gao X, Liu Q, et al. Biosynthesis of polyhydroxyalkanoate copolyesters by Aeromonas hydrophila mutant expressing a low-substrate-specificity PHA synthase PhaC2 Ps. Biochem Eng J. 2007;37:144–150.
  • Han J, Lu Q, Zhou L, et al. Identification of the polyhydroxyalkanoate (PHA)-specific acetoacetyl coenzyme A reductase among multiple FabG paralogs in Haloarcula hispanica and reconstruction of the PHA biosynthetic pathway in Haloferax volcanii. Appl Environ Microbiol. 2009;75:6168–6175.
  • Licciardello G, Devescovi G, Bella P. Transcriptional Analysis of Pha Genes in Pseudomonas Mediterranea CFBP 5447 Grown on Glycerol. Chem Eng Trans. 2014;38:978–988.
  • Wittgens A, Tiso T, Arndt TT, et al. Growth independent rhamnolipid production from glucose using the non-pathogenic Pseudomonas putida KT2440. Microb Cell Fact. 2011;10:1.
  • Fennessy D, Grallert A, Krapp ACokoja A, Bridge AJ., Petersen J, Patel A, Tallada VA, Boke E, Hodgson B, Simanis V, Hagan IM. Extending the Schizosaccharomyces pombe molecular genetic toolbox. PLoS One.2014 May 21;9(5):e97683. doi:10.1371/journal.pone.0097683. eCollection 2014
  • Chaitanya K, Mahmood. SK, Kausar R. Biotechnological Production of Polyhydroxyalkonates by Various Isolates: A Review. Int J Pharm Sci Invention. 2014;3:1–11.
  • Kamilah H, Tsuge T, Yang TA, et al. Waste cooking oil as substrate for biosynthesis of poly (3-hydroxybutyrate) and poly (3-hydroxybutyrate-co-3-hydroxyhexanoate): turning waste into a value-added product. Malaysian J Microbiol. 2013;9:51–59.
  • Hoefer P. Activation of polyhydroxyalkanoates: functionalization and modification. Front Biosci. 2010;15:93–121.
  • Cavalheiro JMBT, de Almeida MCMD, Grandfils C, et al. Poly(3-hydroxybutyrate) production by Cupriavidus necator using waste glycerol. Process Biochem. 2009;44:509–515.
  • Valappil SP, Boccaccini AR, Bucke C, et al. Polyhydroxyalkanoates in Gram-positive bacteria: insights from the genera Bacillus and Streptomyces, Antonie van Leeuwenhoek. Int J Gen Mol Microbiol. 2007;91:1–17.
  • DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11–20.
  • Doi Y, Kawaguchi Y, Koyama N, et al. Synthesis and degradation of polyhydroxyalkanoates in Alcaligenes eutrophus. FEMS Microbiol Rev. 1992;9:103–108.
  • Lee SY. Bacterial polyhydroxyalkanoates. Biotechnol Bioeng. 1996;49:1–14.
  • Mukhopadhyay M, Patra A, Paul AK. Production of poly (3-hydroxybutyrate) and poly (3-hydroxybutyrate-co-3-hydroxyvalerate) by Rhodopseudomonas palustris SP5212. World J Microbiol Biotechnol. 2005;21:765–769.
  • Lakshman K, Shamala TR. Enhanced biosynthesis of polyhydroxyalkanoates in a mutant strain of Rhizobium meliloti. Biotechnol Lett. 2003;25:115–119.
  • Genser KF, Renner G, Schwab H. Molecular cloning, sequencing and expression in Escherichia coli of the poly (3-hydroxyalkanoate) synthesis genes from Alcaligenes latus DSM1124. J Biotechnol. 1998;64:123–135.
  • Wang WS, Lundgren DG. Poly-beta-hydroxybutyrate in the chemolithotrophic bacterium Ferrobacillus ferrooxidans. J Bacteriol. 1969;97:947.
  • Kim YB, Lenz RW Polyesters from microorganisms. In: Biopolyesters. Berlin, Heidelberg: Springer; 2001. p. 51–79.
  • Chien -C-C, Chen -C-C, Choi M-H, et al. Production of poly-β-hydroxybutyrate (PHB) by Vibrio spp. isolated from marine environment. J Biotechnol. 2007;132:259–263.
  • Takeda M, Koizumi J-I, Yabe K, et al. Thermostable poly (3-hydroxybutyrate) depolymerase of a thermophilic strain of Leptothrix sp. isolated from a hot spring. J Ferment Bioeng. 1998;85:375–380.
  • López-Cortés A, Lanz-Landázuri A, García-Maldonado JQ. Screening and isolation of PHB-producing bacteria in a polluted marine microbial mat. Microb Ecol. 2008;56:112–120.
  • Kushnaryov VM, Dunne WM, Buckmire FLA. Electron microscopy of Malachite Green—glutaraldehyde fixed bacteria. Stain Technol. 1979;54:331–336.
  • Boynton ZL, Koon JJ, Brennan EM, et al. Reduction of cell lysate viscosity during processing of poly (3-hydroxyalkanoates) by chromosomal integration of the staphylococcal nuclease gene in Pseudomonas putida. Appl Environ Microbiol. 1999;65:1524–1529.
  • Williams DR, Anderson AJ, Dawes EA, et al. Production of a co-polyester of 3-hydroxybutyric acid and 3-hydroxyvaleric acid from succinic acid by Rhodococcus ruber: biosynthetic considerations. Appl Microbiol Biotechnol. 1994;40:717–723.
  • Valentin HF, Dennis D. Metabolic pathway for poly (3-hydroxybutyrate-co-3-hydroxyvalerate) formation in Nocardia corallina: inactivation of mutB by chromosomal integration of a kanamycin resistance gene. Appl Environ Microbiol. 1996;62:372–379.
  • Sharma L, Mallick N. Accumulation of poly-β-hydroxybutyrate in Nostoc muscorum: regulation by pH, light–dark cycles, N and P status and carbon sources. Bioresour Technol. 2005;96:1304–1310.
  • Boyandin AN, Kalacheva GS, Rodicheva EK, et al. Synthesis of reserve polyhydroxyalkanoates by luminescent bacteria. Microbiology. 2008;77:318–323.
  • Smith RL, West TP, Gibbons WR. Rhodospirillum rubrum: utilization of condensed corn solubles for poly‐(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) production. J Appl Microbiol. 2008;104:1488–1494.
  • Ying TH, Ishii D, Mahara A, et al. Scaffolds from electrospun polyhydroxyalkanoate copolymers: fabrication, characterization, bioabsorption and tissue response. Biomaterials. 2008;29:1307–1317.
  • Qu X-H, Wu Q, Zhang K-Y, et al. In vivo studies of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: biodegradation and tissue reactions. Biomaterials. 2006;27:3540–3548.
  • Sevastianov VI, Perova NV, Shishatskaya EI, et al. Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. J Biomater Sci Polym Educ. 2003;14:1029–1042.
  • Grage K, Jahns AC, Parlane N, et al. Bacterial Polyhydroxyalkanoate Granules: biogenesis, Structure, and Potential Use as Nano-/Micro-Beads in Biotechnological and Biomedical Applications. Biomacromolecules. 2009;10:660–669.
  • Zinn M, Witholt B, Egli T. Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate. Adv Drug Delivery Rev. 2001;53:5–21.
  • Shishatskaya EI, Volova TG, Puzyr AP, et al. Tissue morphogenesis under the conditions of implantation of polyhydroxybutyrate, a biodegradable polymer. Doklady Biol Sci. 2002;383:123–126.
  • Shishatskaya EI, Volova TG, Puzyr AP, et al. Tissue response to the implantation of biodegradable polyhydroxyalkanoate sutures. J Mater Sci Mater Med. 2004;15:719–728.
  • Shishatskaya EI, Voinova ON, Goreva AV, et al. Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation. J Mater Sci Mater Med. 2008;19:2493–2502.
  • Shishatskaya EI, Volova TG, Gitelson II. On the involvement of macrophages and phosphomonoesterases in the tissue response to implantation of polyhydroxyalkanoates. Doklady Biol Sci. 2002;383:116–119.
  • Shishatskaya EI, Volova TG, Gitelson II. In vivo toxicological evaluation of polyhydroxyalkanoates. Doklady Biol Sci. 2002;383:109–111.
  • Leenstra TS, Kuijpers-Jagtman AM, Maltha JC. The healing process of palatal tissues after palatal surgery with and without implantation of membranes: an experimental study in dogs. J Mater Sci Mater Med. 1998;9:249–255.
  • Lu X-Y, Wu D-C, Li Z-J, et al. Polymer Nanoparticles. Prog Mol Biol Transl Sci. 2011;104:299–323.
  • Nobes GAR, Marchessault RH, Maysinger D. Polyhydroxyalkanoates: materials for delivery systems. Drug Delivery J Delivery Target Ther Agents. 1998;5:167–177.
  • Gangrade N, Price JC. Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties. J Microencapsul. 1991;8:185–202.
  • Murueva AV, Shishatskaya EI, Kuzmina AM, et al. Microparticles prepared from biodegradable polyhydroxyalkanoates as matrix for encapsulation of cytostatic drug. J Mater Sci Mater Med. 2013;24:1905–1915.
  • Salman MA, Sahin A, Onur MA, et al. Tramadol encapsulated into polyhydroxybutyrate microspheres. Acta Anaesthesiol Scand. 2003;47:1006–1012.
  • Mohamed S, Amirul AAA, Effendy AWM, et al. Characterization and cytotoxicity of Polyhydroxyalkanoate microparticles as adjuvant matrix for the immobilization of Pasteurella multocida whole-cell vaccine. J Sustain Sci Manage. 2017;12:89–95.
  • Dong Y, Zhang X, Zhang C, et al. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. Eur J Pharm Biopharm. 2010;76:10–16.
  • Rossi S, Azghani AO, Omri A. Antimicrobial efficacy of a new antibiotic-loaded poly (hydroxybutyric-co-hydroxyvaleric acid) controlled release system. J Antimicrob Chemother. 2004;54:1013–1018.
  • Basnett P, Ching KY, Stolz M, et al. Aspirin-loaded P(3HO)/P(3HB) blend films: potential materials for biodegradable drug-eluting stents. Bioinspired Biomimetric Nanobiomater. 2013;2:141–153.
  • Peng K, Wu C, Wei G, et al. Implantable sandwich PHBHHx film for burst-free controlled delivery of thymopentin peptide. Acta Pharm Sin B. 2018;8:432–439.
  • Nigmatullin R, Thomas P, Lukasiewicz B, et al. Polyhydroxyalkanoates, a family of natural polymers, and their applications in drug delivery. J Chem Technol Biotechnol. 2015;90:1209–1221.
  • Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci. 2011;36:887–913.
  • Coccoli V, Luciani A, Orsi S, et al. Engineering of poly(ε-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic. J Mater Sci Mater Med. 2008;19:1703–1711.
  • Biondi M, Guarnieri D, Yu H, et al. Sub-100 nm biodegradable nanoparticles: in vitro release features and toxicity testing in 2D and 3D cell cultures. Nanotechnology. 2013;24:045101.
  • Shrivastav A, Kim H-Y, Kim Y-R. Advances in the applications of polyhydroxyalkanoate nanoparticles for novel drug delivery system. Biomed Res Int. 2013;581684. Article ID 581684, 12 pages.
  • Orts WJ, Nobes GAR, Kawada J, et al. Poly(hydroxyalkanoates): biorefinery polymers with a whole range of applications. The work of Robert H. Marchessault. 2011. DOI:10.1139/v08-050.
  • Govindasamy S, Syafiq IM, Amirul -A-A-A, et al. Dataset on controlled production of polyhydroxyalkanoate-based microbead using double emulsion solvent evaporation technique. Data Br. 2019;23:103675.
  • Kilicay E, Karahaliloglu Z, Hazer B, et al. Concanavaline A conjugated bacterial polyester-based PHBHHx nanoparticles loaded with curcumin for breast cancer therapy. J Microencapsul. 2016;33:274–285.
  • Kiliay E, Demirbilek M, Türk M, et al. Preparation and characterization of poly(3-hydroxybutyrate-co-3- hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Eur J Pharm Sci. 2011;44:310–320.
  • Masood F, Chen P, Yasin T, et al. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. Mater Sci Eng C. 2013;33:1054–1060.
  • Pramual S, Assavanig A, Bergkvist M, et al. Development and characterization of bio-derived polyhydroxyalkanoate nanoparticles as a delivery system for hydrophobic photodynamic therapy agents. J Mater Sci Mater Med. 2016;27:40.
  • Kassab AC, Xu K, Denkbas EB, et al. Rifampicin carrying polyhydroxybutyrate microspheres as a potential chemoembolization agent. J Biomater Sci Polym Educ. 1997;8:947–961.
  • Yagmurlu MF, Korkusuz F, Guersel I, et al. Sulbactam‐cefoperazone polyhydroxybutyrate‐co‐hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant‐related experimental osteomyelitis. J Biomed Mater Res. 1999;46:494–503.
  • Li H, Chang J. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. J Control Release. 2005;107:463–473.
  • Yao Y-C, Zhan X-Y, Zhang J, et al. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands. Biomaterials. 2008;29:4823–4830.
  • Gursel I, Yagmurlu F, Korkusuz F, et al. In vitro antibiotic release from poly (3-hydroxybutyrate-co-3-hydroxyvalerate) rods. J Microencapsul. 2002;19:153–164.
  • Türesin F, Gürsel I, Hasirci V. Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. J Biomater Sci Polym Educ. 2001;12:195–207.
  • Shishatskaya EI, Goreva AV, Voinova ON, et al. Evaluation of antitumor activity of rubomycin deposited in absorbable polymeric microparticles. Bull Exp Biol Med. 2008;145:358–361.
  • Vardhan H, Mittal P, Adena SKR, et al. Development of long-circulating docetaxel loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles: optimization, pharmacokinetic, cytotoxicity and in vivo assessments. Int J Biol Macromol. 2017;103:791–801.
  • Vardhan H, Mittal P, Adena SKR, et al. Process optimization and in vivo performance of docetaxel loaded PHBV-TPGS therapeutic vesicles: A synergistic approach. Int J Biol Macromol. 2018;108:729–743.
  • Şahin A, Eke G, Buyuksungur A, et al. Nuclear targeting peptide-modified, DOX-loaded, PHBV nanoparticles enhance drug efficacy by targeting to Saos-2 cell nuclear membranes. J Biomater Sci Polym Ed. 2018;29:507–519.
  • Rezaie Shirmard L, Bahari Javan N, Khoshayand MR, et al. Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation. Pharm Dev Technol. 2017;22:860–870.
  • Bahari Javan N, Jafary Omid N, Moosavi Hasab N, et al. Preparation, statistical optimization and in vitro evaluation of pramipexole prolonged delivery system based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles. J Drug Deliv Sci Technol. 2018;44:82–90.
  • Chen C, Yu CH, Cheng YC, et al. Preparation and characterization of biodegradable nanoparticles based on amphiphilic poly(3-hydroxybutyrate)–poly(ethylene glycol)–poly(3-hydroxybutyrate) triblock copolymer. Eur Polym J. 2006;42:2211–2220.
  • Kapoor S, Gupta D, Kumar M, et al. Intracellular delivery of peptide cargos using polyhydroxybutyrate based biodegradable nanoparticles: studies on antitumor efficacy of BCL-2 converting peptide, NuBCP-9. Int J Pharm. 2016;511:876–889.
  • Wang X, Liow SS, Wu Q, et al. Codelivery for Paclitaxel and Bcl-2 Conversion Gene by PHB-PDMAEMA Amphiphilic Cationic Copolymer for Effective Drug Resistant Cancer Therapy. Macromol Biosci. 2017;17:1700186.
  • Cheng H, Wu Z, Wu C, et al. Overcoming STC2 mediated drug resistance through drug and gene co-delivery by PHB-PDMAEMA cationic polyester in liver cancer cells. Mater Sci Eng C. 2018;83:210–217.
  • Abdelwahab M, Salahuddin N, Gaber M, et al. Poly(3-hydroxybutyrate)/polyethylene glycol-NiO nanocomposite for NOR delivery: antibacterial activity and cytotoxic effect against cancer cell lines. Int J Biol Macromol. 2018;114:717–727.
  • Wu Y-L, Wang H, Qiu Y-K, et al. PHB-Based Gels as Delivery Agents of Chemotherapeutics for the Effective Shrinkage of Tumors. Adv Healthc Mater. 2016;5:2679–2685.
  • Shah M, Naseer MI, Choi MH, et al. Amphiphilic PHA–mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. Int J Pharm. 2010;400:165–175.
  • Zhou L, Chen Z, Chi W, et al. Mono-methoxy-poly(3-hydroxybutyrate-co-4-hydroxybutyrate)-graft-hyper-branched polyethylenimine copolymers for siRNA delivery. Biomaterials. 2012;33:2334–2344.
  • Bahari Javan N, Rezaie Shirmard L, Jafary Omid N, et al. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. J Microencapsul. 2016;33:460–474.
  • Bini RA, Silva MF, Varanda LC, et al. Soft nanocomposites of gelatin and poly(3-hydroxybutyrate) nanoparticles for dual drug release. Colloids Surf B Biointerfaces. 2017;157:191–198.
  • Alizadeh B, Bahari Javan N, Akbari Javar H, et al. Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system. Pharm Dev Technol. 2018;23:132–144.
  • Fernandes JG, Correia DM, Botelho G, et al. PHB-PEO electrospun fiber membranes containing chlorhexidine for drug delivery applications. Polym Test. 2014;34:64–71.
  • Cao K, Liu Y, Olkhov AA, et al. PLLA-PHB fiber membranes obtained by solvent-free electrospinning for short-time drug delivery. Drug Delivery Trans Res. 2018;8:291–302.
  • Sachlos E, Czernuszka JT. Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater. 2003;5:39–40.
  • Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotech. 2005;23:47–55.
  • Malafaya PB, Silva GA, Reis RL. Natural–origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Delivery Rev. 2007;59:207–233.
  • Misra SK, Valappil SP, Roy I, et al. Polyhydroxyalkanoate (PHA)/Inorganic Phase Composites for Tissue Engineering Applications. Biomacromolecules. 2006;7:2249–2258.
  • Chen G-Q, Wu Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials. 2005;26:6565–6578.
  • Koller M.Advances in Polyhydroxyalkanoate (PHA) Production. Bioengineering (Basel). 2017;4(4):88.
  • Michalak M, Kurcok P, Hakkarainen M. Polyhydroxyalkanoate-based drug delivery systems. Polym Int. 2017;66:617–622.
  • Guarino V, Gloria A, Raucci MG, et al. Bio-inspired composite and cell instructive platforms for bone regeneration. Int Mater Rev. 2012;57:256–275.
  • Guarino V, Gloria A, Raucci MG, et al. Hydrogel-Based Platforms for the Regeneration of Osteochondral Tissue and Intervertebral Disc. Polymers (Basel). 2012;4:1590–1612.
  • Taherkhani S, Moztarzadeh F. Fabrication of a poly(ɛ-caprolactone)/starch nanocomposite scaffold with a solvent-casting/salt-leaching technique for bone tissue engineering applications. J Applied Polym Sci. 2016;133:23. doi:10.1002/app.43523.
  • Bian Y-Z, Wang Y, Aibaidoula G, et al. Evaluation of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) conduits for peripheral nerve regeneration. Biomaterials. 2009;30:217–225.
  • Köse GT, Ber S, Korkusuz F, et al. Poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) based tissue engineering matrices. J Mater Sci Mater Med. 2003;14:121–126.
  • Köse GT, Korkusuz F, Korkusuz P, et al. Bone generation on PHBV matrices: an in vitro study. Biomaterials. 2003;24:4999–5007.
  • Deng Y, Zhao K, Zhang X, et al. Study on the three-dimensional proliferation of rabbit articular cartilage-derived chondrocytes on polyhydroxyalkanoate scaffolds. Biomaterials. 2002;23:4049–4056.
  • Rouwkema J, Rivron NC, van Blitterswijk CA. Vascularization in tissue engineering. Trends Biotechnol. 2008;26:434–441.
  • Bugnicourt E, Cinelli P, Lazzeri A, et al. Polyhydroxyalkanoate (PHA): review of synthesis, characteristics, processing and potential applications in packaging. Express Polym Lett. 2014;8:791–808.
  • Guarino V, Causa F, Salerno A, et al. Design and manufacture of microporous polymeric materials with hierarchal complex structure for biomedical application. Mater Sci Technol. 2008;24:1111–1117.
  • Ansari NF, Amirul AA. Preparation and Characterization of Polyhydroxyalkanoates Macroporous Scaffold Through Enzyme-Mediated Modifications. Appl Biochem Biotechnol. 2013;170:690–709.
  • Nemati Hayati A, Hosseinalipour SM, Rezaie HR, et al. Characterization of poly(3-hydroxybutyrate)/nano-hydroxyapatite composite scaffolds fabricated without the use of organic solvents for bone tissue engineering applications. Mater Sci Eng C. 2012;32:416–422.
  • Çiçek Ç, Çakmakçi E, Kayaman-Apohan N, et al. Fabrication of PLGA Based Tissue Engineering Scaffolds via Photocuring and Salt Leaching Techniques. Int J Polym Mater. 2013;62:719–725.
  • Zhijiang C, Guoxiang C, Mingming G, et al. Layered-lamination Preparing of Tissue Engineering Scaffolds via Emulsion Templates Method. J Polym Res. 2004;11:225–230.
  • Zhijiang C. Biocompatibility and Biodegradation of novel PHB porous substrates with controlled multi-pore size by emulsion templates method. J Mater Sci Mater Med. 2006;17:1297–1303.
  • Cox SC, Thornby JA, Gibbons GJ, et al. 3D printing of porous hydroxyapatite scaffolds intended for use in bone tissue engineering applications. Mater Sci Eng C. 2015;47:237–247.
  • Pereira TF, Oliveira MF, Maia IA, et al. 3D Printing of Poly(3-hydroxybutyrate) Porous Structures Using Selective Laser Sintering. Macromol Symp. 2012;319:64–73.
  • Duan B, Cheung WL, Wang M. Optimized fabrication of Ca–P/PHBV nanocomposite scaffolds via selective laser sintering for bone tissue engineering. Biofabrication. 2011;3:015001.
  • Berger M, Probst F, Schwartz C, et al. A concept for scaffold-based tissue engineering in alveolar cleft osteoplasty. J Cranio-Maxillofacial Surg. 2015;43:830–836.
  • Puppi D, Morelli A, Chiellini F. Additive Manufacturing of Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)/poly(ε-caprolactone) Blend Scaffolds for Tissue Engineering. Bioengineering. 2017;4:49.
  • Cima LG, Vacanti JP, Vacanti C, et al. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng. 1991;113:143–151.
  • Klawitter JJ, Hulbert SF. Application of porous ceramics for the attachment of load bearing internal orthopedic applications. J Biomed Mater Res. 1971;5:161–229.
  • Whang K, Thomas CH, Healy KE, et al. A novel method to fabricate bioabsorbable scaffolds. Polymer (Guildf). 1995;36:837–842.
  • Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues-state of the art and future perspectives. J Biomater Sci. 2001;12:107–124.
  • Hannink G, Arts JJC. Bioresorbability, porosity and mechanical strength of bone substitutes: what is optimal for bone regeneration? Injury. 2011;42:S22–S25.
  • Chen G-Q, Zhang J. Microbial polyhydroxyalkanoates as medical implant biomaterials. Artif Cells Nanomed Biotechnol. 2018;46:1–18.
  • Guarino V, Ambrosio L. Temperature-driven processing techniques for manufacturing fully interconnected porous scaffolds in bone tissue engineering. Proc Inst Mech Eng Part H J Eng Med. 2010;224:1389–1400.
  • Xi J, Li J, Zhu L, et al. Effects of Quenching Temperature and Time on Pore Diameter of Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) Porous Scaffolds and MC3T3-E1 Osteoblast Response to the Scaffolds. Tsinghua Sci Technol. 2007;12:366–371.
  • Nie T, He M, Ge M, et al. Fabrication and structural regulation of PLLA porous microspheres via phase inversion emulsion and thermally induced phase separation techniques. J. Appl. Polym. Sci. 2017;134:44885.
  • Guarino V, Cirillo V, Ambrosio L. Bicomponent electrospun scaffolds to design extracellular matrix tissue analogs. Expert Rev Med Devices. 2016;13:83–102.
  • Cirillo V, Guarino V, Alvarez-Perez MA, et al. Optimization of fully aligned bioactive electrospun fibers for “in vitro” nerve guidance. J Mater Sci Mater Med. 2014;25:2323–2332.
  • Guarino V, Ambrosio L. Electrofluidodynamics: exploring a new toolbox to design biomaterials for tissue regeneration and degeneration. Nanomedicine. 2016;11:1515–1518.
  • Fu N, Deng S, Fu Y, et al. Electrospun P34HB fibres: a scaffold for tissue engineering. Cell Prolif. 2014;47:465–475.
  • Masaeli E, Morshed M, Rasekhian P, et al. Does the tissue engineering architecture of poly(3-hydroxybutyrate) scaffold affects cell-material interactions? J Biomed Mater Res Part A. 2012;100A:1907–1918.
  • Ramier J, Ben Boubaker M, Guerrouache M, et al. Novel routes to epoxy functionalization of PHA-based electrospun scaffolds as ways to improve cell adhesion. J Polym Sci Part A Polym Chem. 2014;52:816–824.
  • Renard E, Timbart L, Vergnol G, et al. Role of carboxyl pendant groups of medium chain length poly(3-hydroxyalkanoate)s in biomedical temporary applications. J Appl Polym Sci. 2010;117:1888–1896.
  • Rai R, Boccaccini AR, Knowles JC, et al. The homopolymer poly(3-hydroxyoctanoate) as a matrix material for soft tissue engineering. J Appl Polym Sci. 2011;122:3606–3617.
  • Lemechko P, Renard E, Guezennec J, et al. Synthesis of dextran-graft-PHBHV amphiphilic copolymer using click chemistry approach. React Funct Polym. 2012;72:487–494.
  • Guarino V, Altobelli R, Cirillo V, et al. Additive electrospraying: a route to process electrospun scaffolds for controlled molecular release. Polym Adv Technol. 2015;26:1359–1369.
  • Ramier J, Bouderlique T, Stoilova O, et al. Biocomposite scaffolds based on electrospun poly(3-hydroxybutyrate) nanofibers and electrosprayed hydroxyapatite nanoparticles for bone tissue engineering applications. Mater Sci Eng C. 2014;38:161–169.
  • Rathbone S, Furrer P, Lübben J, et al. Biocompatibility of polyhydroxyalkanoate as a potential material for ligament and tendon scaffold material. J Biomed Mater Res Part A. 2010;93:1391–1403.
  • Zheng Z, Bei -F-F, Tian H-L, et al. Effects of crystallization of polyhydroxyalkanoate blend on surface physicochemical properties and interactions with rabbit articular cartilage chondrocytes. Biomaterials. 2005;26:3537–3548.
  • Zheng Z, Deng Y, Lin X-S, et al. Induced production of rabbit articular cartilage-derived chondrocyte collagen II on polyhydroxyalkanoate blends. J Biomater Sci Polym Ed. 2003;14:615–624.
  • Yu L, Dean K, Li L. Polymer blends and composites from renewable resources. Prog Polym Sci. 2006;31:576–602.
  • An Y, Dong L, Xing P, et al. Crystallization kinetics and morphology of poly(β-hydroxybutyrate) and poly(vinyl acetate) blends. Eur Polym J. 1997;33:1449–1452.
  • You J-W, Chiu H-J, Don T-M. Spherulitic morphology and crystallization kinetics of melt-miscible blends of poly(3-hydroxybutyrate) with low molecular weight poly(ethylene oxide). Polymer (Guildf). 2003;44:4355–4362.
  • Method for Production of Nanofibres. Google Patents; 2010.
  • Yalpani M, Marchessault RH, Morin FG, et al. Synthesis of poly(3-hydroxyalkanoate) (PHA) conjugates: PHA-carbohydrate and PHA-synthetic polymer conjugates. Macromolecules. 1991;24:6046–6049.
  • Zhang WJ, Liu W, Cui L, et al. Tissue engineering of blood vessel. J Cell Mol Med. 2007;11:945–957.
  • Bioresorbable scaffolds for cardiovascular tissue engineering. EMJ Int Cardiol. 2014;1(1):91-99.
  • Shum-Tim D, Stock U, Hrkach J, et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg. 1999;68:2298–2304.
  • Hoerstrup SP. Functional Growth in Tissue-Engineered Living, Vascular Grafts: follow-Up at 100 Weeks in a Large Animal Model. Circulation. 2006;114:I-159-I–166.
  • Sodian R, Hoerstrup SP, Sperling JS, et al. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. ASAIO J. 2000;46:107–110.
  • Sodian R, Hoerstrup SP, Sperling JS, et al. Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg. 2000;70:140–144.
  • Bagdadi AV, Safari M, Dubey P, et al. Poly(3-hydroxyoctanoate), a promising new material for cardiac tissue engineering. J Tissue Eng Regen Med. 2018;12:e495–e512.
  • Doyle C, Tanner ET, Bonfield W. In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite. Biomaterials. 1991;12:841–847.
  • Abdal-Hay A, Sheikh FA, Lim JK. Air jet spinning of hydroxyapatite/poly(lactic acid) hybrid nanocomposite membrane mats for bone tissue engineering. Colloids Surf B Biointerfaces. 2013;102:635–643.
  • Abdal-Hay A, Tijing LD, Lim JK. Characterization of the surface biocompatibility of an electrospun nylon 6/CaP nanofiber scaffold using osteoblasts. Chem Eng J. 2013;215–216:57–64.
  • Hench LL. Bioceramics: from concept to clinic. J Am Ceram Soc. 1991;74:1487–1510.
  • Varma HK, Suresh Babu S. Synthesis of calcium phosphate bioceramics by citrate gel pyrolysis method. Ceram Int. 2005;31:109–114.
  • Khalil KA, Kim SW, Kim HY. Consolidation and mechanical properties of nanostructured hydroxyapatite–(zrO2+3mol% Y2O3) bioceramics by high-frequency induction heat sintering. Mater Sci Eng A. 2007;456:368–372.
  • Ducheyne P, Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials. 1999;20:2287–2303.
  • Allo BA, Rizkalla AS, Mequanint K. Hydroxyapatite formation on sol-gel derived poly(epsilon-caprolactone)/bioactive glass hybrid biomaterials. ACS Appl Mater Interfaces. 2012;4:3148–3156.
  • Wei L, Ke J, Prasadam I, et al. A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects. Osteoporos Int. 2014;25:2089–2096.
  • Kokubo T, Kim HM, Kawashita M. Novel bioactive materials with different mechanical properties. Biomaterials. 2003;24:2161–2175.
  • Kim HW, Kim HE, Knowles JC. Production and Potential of Bioactive Glass Nanofibers as a Next-Generation Biomaterial. Adv Funct Mater. 2006;16:1529–1535.
  • Lee HH, Yu HS, Jang JH, et al. Bioactivity improvement of poly(epsilon-caprolactone) membrane with the addition of nanofibrous bioactive glass. Acta Biomater. 2008;4:622–629.
  • Li X, Qu F, Li W, et al. Synthesis of hierarchically porous bioactive glasses using natural plants as template for bone tissue regeneration. J Sol-Gel Sci Technol. 2012;63:416–424.
  • Abdal-Hay A, Lim J, Shamshi Hassan M, et al. Ultrathin conformal coating of apatite nanostructures onto electrospun nylon 6 nanofibers: mimicking the extracellular matrix. Chem Eng J. 2013;228:708–716.
  • Abdal-Hay A, Vanegas P, Hamdy AS, et al. Preparation and characterization of vertically arrayed hydroxyapatite nanoplates on electrospun nanofibers for bone tissue engineering. Chem Eng J. 2014;254:612–622.
  • Wang M, Joseph R, Bonfield W. Hydroxyapatite-polyethylene composites for bone substitution: effects of ceramic particle size and morphology. Biomaterials. 1998;19(24):2357-66.
  • Kourmentza C, Plácido J, Venetsaneas N, et al. Recent Advances and Challenges towards Sustainable Polyhydroxyalkanoate (PHA) Production. Bioengineering. 2017;4:55.
  • Scheithauer EC, Li W, Ding Y, et al. Preparation and characterization of electrosprayed daidzein–loaded PHBV microspheres, Mater. Lett. 2015;158:66–69.
  • Chaturvedi K, Kulkarni AR, Aminabhavi TM. Blend Microspheres of Poly(3-hydroxybutyrate) and Cellulose Acetate Phthalate for Colon Delivery of 5-Fluorouracil. Ind Eng Chem Res. 2011;50:10414–10423.
  • Rezaie Shirmard L, Bahari Javan N, Khoshayand MR, et al. Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation. Pharm Dev Technol. 2017;22:860–870.
  • Volova T, Shishatskaya E, Sevastianov V, et al. Results of biomedical investigations of PHB and PHB/PHV fibers. Biochem Eng J. 2003;16:125–133.
  • Christopher J. Brigham, Anthony J. Sinskey, Applications of Polyhydroxyalkanoates in the Medical Industry. International Journal of Biotechnology for Wellness Industries. 2012;1:53-60.
  • Basnett P, Ching KY, Stolz M, et al. Novel Poly(3-hydroxyoctanoate)/Poly(3-hydroxybutyrate) blends for medical applications. React Funct Polym. 2013;73:1340–1348.
  • Vilos CA, Constandil L, Herrera N, et al. Ceftiofur-loaded PHBV microparticles: A potential formulation for a long-acting antibiotic to treat animal infections. Electron J Biotechnol. 2012;15. doi:10.2225/vol15-issue4-fulltext-2.
  • Masood F. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C. 2016;60:569–578.
  • Barouti G, Jarnouen K, Cammas-Marion S, et al. Polyhydroxyalkanoate-based amphiphilic diblock copolymers as original biocompatible nanovectors. Polym Chem. 2015;6:5414–5429.
  • Adschiri T, Yoko A. Supercritical fluids for nanotechnology. J Supercrit Fluids. 2018;134:167–175.
  • Altobelli R, Guarino V, Ambrosio L. Micro- and nanocarriers by electrofludodynamic technologies for cell and molecular therapies. Process Biochem. 2016;51:2143–2154.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.